AAAAAA

   
Results: 1-10 |
Results: 10
Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial
Authors: Guerrieri-Gonzaga, A Baglietto, L Johansson, H Bonanni, B Robertson, C Sandri, MT Canigiula, L Lampreda, C Diani, S Lien, EA Decensi, A
Citation: A. Guerrieri-gonzaga et al., Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial, CANC EPID B, 10(9), 2001, pp. 967-970
Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women
Authors: Bonanni, B Johansson, H Gandini, S Guerrieri-Gonzaga, A Torrisi, R Sandri, MT Cazzaniga, M Mora, S Robertson, C Lien, EA Decensi, A
Citation: B. Bonanni et al., Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women, BREAST CANC, 69(1), 2001, pp. 21-27
Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum
Authors: Ulvik, A Evensen, ET Lien, EA Hoff, G Vollset, SE Majak, BM Ueland, PM
Citation: A. Ulvik et al., Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum, AM J MED G, 101(3), 2001, pp. 246-254
Total plasma homocysteine in hypo- and hyperthyroidism: Covariations and causality
Authors: Lien, EA Hustad, S Nedrebo, BG Nygard, O Ueland, PM
Citation: Ea. Lien et al., Total plasma homocysteine in hypo- and hyperthyroidism: Covariations and causality, J CLIN END, 86(4), 2001, pp. 1846-1846
Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment
Authors: Nedrebo, BG Nygard, O Ueland, PM Lien, EA
Citation: Bg. Nedrebo et al., Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment, CLIN CHEM, 47(9), 2001, pp. 1738-1741
Selective oestrogen receptor modifiers (SERMs) and breast cancer therapy
Authors: Lien, EA Lonning, PE
Citation: Ea. Lien et Pe. Lonning, Selective oestrogen receptor modifiers (SERMs) and breast cancer therapy, CANC TR REV, 26(3), 2000, pp. 205-227
Plasma total homocysteine levels during short-term iatrogenic hypothyroidism
Authors: Lien, EA Nedrebo, BG Varhaug, JE Nygard, O Aakvaag, A Ueland, PM
Citation: Ea. Lien et al., Plasma total homocysteine levels during short-term iatrogenic hypothyroidism, J CLIN END, 85(3), 2000, pp. 1049-1053
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy women
Authors: Decensi, A Gandini, S Guerrieri-Gonzaga, A Johansson, H Manetti, L Bonanni, B Sandri, MT Barreca, A Costa, A Robertson, C Lien, EA
Citation: A. Decensi et al., Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy women, J CL ONCOL, 17(9), 1999, pp. 2633-2638
Serum homocysteine levels in postmenopausal breast cancer patients treatedwith tamoxifen
Authors: Love, RR Anker, G Yang, YH Refsum, H Ueland, PM Lonning, PE Lien, EA
Citation: Rr. Love et al., Serum homocysteine levels in postmenopausal breast cancer patients treatedwith tamoxifen, CANCER LETT, 145(1-2), 1999, pp. 73-77
Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients
Authors: Anker, GB Refsum, H Ueland, PM Johannessen, DC Lien, EA Lonning, PE
Citation: Gb. Anker et al., Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients, CLIN CHEM, 45(2), 1999, pp. 252-256
Risultati: 1-10 |